connect2cme's profile picture. We are a provider of independent medical education/CME activities that is proud to do things differently

Connect2 CME

@connect2cme

We are a provider of independent medical education/CME activities that is proud to do things differently

Free EACCME-accredited eLearning modules available now. Course Directors Maria Buti & Geoff Dusheiko connect2cme.learnupon.com #HBV #HCV @Mariabutif

connect2cme's tweet image. Free EACCME-accredited eLearning modules available now. Course Directors Maria Buti & Geoff Dusheiko connect2cme.learnupon.com #HBV #HCV @Mariabutif

Thoughts on new EASL Alcohol and Food Policy Statement #ILC2019

Get a glimpse from the ground on hot topics discussed at #ILC2019 in this ILC Insight



Highlights of day 4 at ILC in Vienna. Another day of interesting debate #ILC2019 #NAFLD #NASH


Looking forward to best of ILC slide decks coming later today #ILC2019 #NAFLD #NASH

Stay tuned tomorrow. The best of #ILC2019 slide decks will be available for download following the wrap up session.

EASLnews's tweet image. Stay tuned tomorrow. The best of #ILC2019 slide decks will be available for download following the wrap up session.


Interactive 'Solve the Case' session on HCV/TB patient by Aisling Considine with thought-provoking discussion #ILC2019 #HCV #liver

connect2cme's tweet image. Interactive 'Solve the Case' session on HCV/TB patient by Aisling Considine with thought-provoking discussion #ILC2019 #HCV #liver

Reasons to attend ILC 2020 in London. Listen to what attendees had to say on day 4 of ILC in Vienna #ILC2019 #NAFLD #NASH

This post is unavailable.

A day of great presentations, interactive Meet the Expert sessions & poster tours #ILC2019

#ILC2019 Day 3 short video is out 📣🤗. See you all soon for more interesting sessions tomorrow- ilc-congress.eu/videos-ilc2019/ @EASLedu @tomhemmingk @MarcoMarzioni74 @JHepatology



'Children of the 90s' study highlights need for greater public health awareness of non-alcoholic fatty liver disease #ILC2019 #NAFLD

#ILC2019 Day 3 short video is out 📣🤗. See you all soon for more interesting sessions tomorrow- ilc-congress.eu/videos-ilc2019/ @EASLedu @tomhemmingk @MarcoMarzioni74 @JHepatology



Free HBV/HCV eLearning now available with certificate! Course Directors Maria Buti & Geoff Dusheiko. connect2cme.learnupon.com #liverdisease #HBV #HCV #NASH @Mariabutif


Connect2 CME reposted

Download & use the #Alcohol related liver disease ppt. slide deck: bit.ly/2LW22wX corresponding to #EASL's 2018 Clinical Practice Guidelines!

EASLnews's tweet image. Download & use the #Alcohol related liver disease ppt. slide deck: bit.ly/2LW22wX  corresponding to #EASL's 2018 Clinical Practice Guidelines!

CSHep slides and webcasts online now! clinscihepatology.com to register. ELearning coming soon... #liverdisease @Mariabutif @BirminghamLiver @BritSocGastro @aelsharkawy75

connect2cme's tweet image. CSHep slides and webcasts online now! clinscihepatology.com to register. ELearning coming soon... #liverdisease @Mariabutif @BirminghamLiver @BritSocGastro @aelsharkawy75

290+ mil are living with viral hepatitis unaware. On World Hepatitis Day, Find the Missing Millions - get tested! thndr.me/bh637y

connect2cme's tweet image. 290+ mil are living with viral hepatitis unaware. On World Hepatitis Day, Find the Missing Millions - get tested! thndr.me/bh637y

9 out of 10 people living with viral hepatitis are unaware. Join the quest to #FindtheMissingMillions on WHD 28 July #WorldHepatitisDay #NOhep #hepatitis


Connect2 CME reposted

Two more days for #SpringTestingWeek which is piloting this year from 18 - 25 May? Don't forget to share your posts, pictures & Tweets with us.@EU_Health @IntegrateJA #EUfundet @ECDC_HIVAIDS @EASLnews @LanaCrnjac @JVLazarus @EASLedu @V_Andriukaitis @rixwolff @hepar_centar

EuropeLiver's tweet image. Two more days for 
#SpringTestingWeek which is piloting this year from 18 - 25 May? Don't forget to share your posts, pictures & Tweets with us.@EU_Health @IntegrateJA #EUfundet @ECDC_HIVAIDS @EASLnews @LanaCrnjac @JVLazarus @EASLedu @V_Andriukaitis  @rixwolff @hepar_centar

Thank you all for coming - some great discussion as wrapped up here by the panel - look out for the materials online and see you at our next event! @Mariabutif #liverdisease #CSHep - ClinSciHepatology.com to register for materials

connect2cme's tweet image. Thank you all for coming - some great discussion as wrapped up here by the panel - look out for the materials online and see you at our next event! @Mariabutif #liverdisease #CSHep - ClinSciHepatology.com to register for materials

Stanislas Pol convinces #CSHep that #HCC patients should be treated for #HCV (74% voted yes, 26% voted no) @liver_cancer #CSHep @EASLedu


TODAY! Free live CME webinar this afternoon - 15:50 UK time / 16:50 Europe - Lawrence Serfaty discussing the identification and best-practice management of fatty liver disease #silentepidemic #NASH #NAFLD #CSHep - ClinSciHepatology.com

connect2cme's tweet image. TODAY! Free live CME webinar this afternoon - 15:50 UK time / 16:50 Europe - Lawrence Serfaty discussing the identification and best-practice management of fatty liver disease #silentepidemic #NASH #NAFLD #CSHep - ClinSciHepatology.com

Jorg Petersen reminding us how HBV RNA (#pgRNA, pre-genomic) should/could be used as an effective “new” biomarker for transcriptional activity of HBV (cccDNA) #HBV #biomarker #CSHep @mariabutif @hlcortezpinto @EASLedu

connect2cme's tweet image. Jorg Petersen reminding us how HBV RNA (#pgRNA, pre-genomic) should/could be used as an effective “new” biomarker for transcriptional activity of HBV (cccDNA) #HBV #biomarker #CSHep @mariabutif
@hlcortezpinto @EASLedu

Jörg Petersen presents data on promising novel therapies (CAMs/RNAi etc) and biomarkers in #HBV. Plenty to discuss ahead of WHO 2030 elimination targets #CShep

connect2cme's tweet image. Jörg Petersen presents data on promising novel therapies (CAMs/RNAi etc) and biomarkers in #HBV. Plenty to discuss ahead of WHO 2030 elimination targets #CShep

Loading...

Something went wrong.


Something went wrong.